Related Experiment Video
Updated: Aug 2, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Infant with severe penicillamine embryopathy born to a woman with Wilson disease
R Pinter1, W A Hogge, E McPherson
1Department of Genetics, Magee-Women's Hospital, Pittsburgh, Pennsylvania, USA. rpinter@mail.magee.edu
Insights
D-penicillamine (DP) exposure during pregnancy can cause rare congenital abnormalities, including cutis laxa and developmental delays. Prenatal monitoring of maternal copper and zinc may aid management in Wilson disease patients.
Area of Science:
- Medical Genetics
- Teratology
- Pediatric Neurology
Background:
- Wilson disease (WD) management during pregnancy necessitates careful consideration of medication safety.
- D-penicillamine (DP) is a chelating agent used for WD, but its teratogenic potential is a concern.
Observation:
- A case of a male infant born with congenital diffuse cutis laxa, severe micrognathia, limb contractures, and central nervous system abnormalities, including agenesis of the corpus callosum.
- The infant's mother was treated with D-penicillamine throughout her pregnancy for Wilson disease.
Findings:
- The infant exhibited a severe phenotype, including chronic lung disease, profound developmental delays, and probable cortical blindness.
- While the infant's cutis laxa resolved postnatally, the overall outcome was poor.
Implications:
- This case highlights the potential for D-penicillamine embryopathy, a rare but severe complication.
- Prenatal assessment of maternal copper and zinc levels may be beneficial for managing pregnant women with Wilson disease on D-penicillamine.
- Further research is needed to elucidate the exact mechanisms and risk factors associated with D-penicillamine embryopathy.
Abstract:
We report a chromosomally normal infant boy with congenital diffuse cutis laxa, severe micrognathia, contractures of all limbs, and central nervous system abnormalities including agenesis of the corpus callosum, born to a woman taking D-penicillamine (DP) for Wilson disease (WD) throughout her pregnancy. His postnatal course was remarkable for chronic lung disease, profound developmental delays, and probable cortical blindness, as well as resolution of his cutis laxa. Embryopathy is a rare complication in babies born to pregnant women treated with DP, and there have been only seven previous reports of birth defects in exposed infants (three of which had favorable postnatal outcomes). The etiology of the severe outcome in this boy is unclear, but prenatal measurement of maternal copper and zinc levels may be indicated for management.
More Related Videos
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
08:53Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment
Published on: March 24, 2026
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Teratogenicity
Rheumatic Heart Disease I: Introduction